Bristol-Myers Squibb (BMY) Insider Trading & Ownership → [URGENT] DO NOT Touch These AI Stocks! (From Weiss Ratings) (Ad) Free BMY Stock Alerts $41.48 +0.60 (+1.47%) (As of 06/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Bristol-Myers Squibb (NYSE:BMY) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.09%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$672,994.06Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$1.15 M Get BMY Insider Trade Alerts Want to know when executives and insiders are buying or selling Bristol-Myers Squibb stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BMY Insider Buying and Selling by Quarter Ad Paradigm PressMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Bristol-Myers Squibb Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails4/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Buy$52.19$1,001 - $15,0004/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$52.19$1,001 - $15,0001/9/2024Rick LarsenU.S. Congress Member (D-WA)Sell$51.27$1,001 - $15,0001/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$52.30$1,001 - $15,00012/5/2023Christopher S BoernerCEOBuy2,000$49.78$99,560.00 11/28/2023Christopher S BoernerCEOBuy3,071$48.86$150,049.06 11/20/2023Theodore R Samuels IIDirectorBuy8,500$49.81$423,385.00 11/16/2023Tommy TubervilleU.S. Congress Member (R-AL)Sell$50.84$1,001 - $15,00010/24/2023Greg StantonU.S. Congress Member (D-AZ)Sell$56.12$1,001 - $15,00010/17/2023Tommy TubervilleU.S. Congress Member (R-AL)Buy$57.38$1,001 - $15,0009/26/2023Greg StantonU.S. Congress Member (D-AZ)Buy$58.54$1,001 - $15,0008/24/2023Ann PowellEVPSell17,986$61.25$1,101,642.50 8/22/2023Dan SullivanU.S. Congress Member (R-AK)Sell$61.86$1,001 - $15,0008/3/2023Robert M PlengeEVPSell732$61.14$44,754.48 (Data available from 1/1/2013 forward) BMY Insider Trading Activity - Frequently Asked Questions Who is on Bristol-Myers Squibb's Insider Roster? The list of insiders at Bristol-Myers Squibb includes Ann Powell, Autenried Paul Von, Christopher S Boerner, David V Elkins, Giovanni Caforio, Karen Murphy Santiago, Robert M Plenge, Rupert Vessey, Sandra Leung, and Theodore R Samuels II. Learn more on insiders at BMY. What percentage of Bristol-Myers Squibb stock is owned by insiders? 0.09% of Bristol-Myers Squibb stock is owned by insiders. Learn more on BMY's insider holdings. Which Bristol-Myers Squibb insiders have been buying company stock? The following insiders have purchased BMY shares in the last 24 months: Christopher S Boerner ($249,609.06), and Theodore R Samuels II ($423,385.00). How much insider buying is happening at Bristol-Myers Squibb? Insiders have purchased a total of 13,571 BMY shares in the last 24 months for a total of $672,994.06 bought. Which Bristol-Myers Squibb insiders have been selling company stock? The following insiders have sold BMY shares in the last 24 months: Ann Powell ($5,012,963.27), David V Elkins ($9,550,706.30), Giovanni Caforio ($25,471,950.00), Robert M Plenge ($44,754.48), and Rupert Vessey ($7,000,198.90). How much insider selling is happening at Bristol-Myers Squibb? Insiders have sold a total of 646,397 Bristol-Myers Squibb shares in the last 24 months for a total of $47,080,572.95 sold. Which members of congress are trading Bristol-Myers Squibb? Tommy Tuberville (R-AL) and Greg Stanton (D-AZ) have bought shares of Bristol-Myers Squibb in the last year totaling $24,000. Tommy Tuberville (R-AL), Rick Larsen (D-WA), Greg Stanton (D-AZ), Dan Sullivan (R-AK), and Daniel S. Goldman (D-NY) have sold shares totaling $80,500. More Insider Trading Tools from MarketBeat Related Companies: Merck & Co., Inc. Insider Buying AbbVie Insider Buying Pfizer Insider Buying Zoetis Insider Buying Royalty Pharma Insider Buying Jazz Pharmaceuticals Insider Buying Perrigo Insider Buying Corcept Therapeutics Insider Buying Supernus Pharmaceuticals Insider Buying Pacira BioSciences Insider Buying Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Top 4 Stocks With Notable Insider Buying3 Small Cap Tech Stocks That Insiders Are Buying3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying This page (NYSE:BMY) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersUrgent alert: open this for a huge profit potentialThis groundbreaking technology that Tim calls “Inception” isn’t being talked about anywhere… not on Fox, Yahoo...Timothy Sykes | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredAre You Positioned For The New Energy Goldrush?Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bristol-Myers Squibb Please log in to your account or sign up in order to add this asset to your watchlist. Share Bristol-Myers Squibb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.